Symbicort Pressurized Inhalation, Powder 160-4.5Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Symbicort: Pressurized inhalation, powder (160-4.5mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Symbicort 160-4.5mcg/act Inh

What is this Medicine?

BUDESONIDE; FORMOTEROL (byoo DES oh nide; for MOH te rol) inhalation is a combination of two medicines that decrease inflammation and help to open up the airways in your lungs. It is used to treat asthma. Do NOT use for an acute asthma attack.

CVS Pharmacy Patient Statistics for Symbicort: Pressurized inhalation, powder(160-4.5mcg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Symbicort 160mcg-4.5mcg/actuation Inhalation Aerosol

NDC: 001860370
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Asthma

Storage Information
Product should be used within 3 months after opening overwrap
Store inhaler with mouthpiece down
Exposure to temperatures above 120 degrees F may cause bursting
Store at controlled room temperature (between 68 and 77 degrees F)
Symbicort 160mcg-4.5mcg/actuation Inhalation Aerosol

Reported Side Effects for Symbicort 160mcg-4.5mcg/actuation Inhalation Aerosol

Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Cataracts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Very Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Irritability Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Restlessness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
High Eye Blood Pressure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
1.0-10.5%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.0-10.5%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
1.0-2.9%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
1.0-2.9%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Dysphoria Incidence:
1.0-2.9%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Fever Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Headache Incidence:
1.0-11.3%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
1.0-2.9%*
Severity: MODERATE
Onset: EARLY
Muscle Cramps Incidence:
1.0-2.9%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
1.4-3.2%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
1.4-3.2%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
1.6-3.2%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
2.4-3.2%*
Severity: MILD
Onset: DELAYED
Stuffy Nose Incidence:
2.5-3.2%*
Severity: MILD
Onset: EARLY
Cough Incidence:
3.0-3.9%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
4.8-5.8%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Symbicort 160mcg-4.5mcg/actuation Inhalation Aerosol

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Symbicort 160mcg-4.5mcg/actuation Inhalation Aerosol(Budesonide)
Grapefruit juice and Budesonide(Budesonide)
Grapefruit juice can increase the amount of oral Budesonide (Entocort-EC) that your body absorbs. Grapefruit juice and grapefruit-containing foods may increase the side effects of oral Budesonide. If possible, you should avoid grapefruit or grapefruit juice while taking Entocort-EC. At the very least, avoid large changes (i.e., either increases or decreases) in your daily intake of grapefruit and grapefruit juice. Grapefruit juice is not expected to interact significantly with inhaled or nasal Budesonide (Pulmicort or Rhinocort).
Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Symbicort 160mcg-4.5mcg/actuation Inhalation Aerosol(Formoterol Fumarate)
Caffeine-containing Foods/Beverages and Beta-agonists(Formoterol Fumarate)
Limit excessive Caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) and limit medicines containing additional Caffeine. In caffeine-sensitive persons, taking a high amount of Caffeine with this drug can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, or other side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Symbicort

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.